TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 615918091

Group type: EXPERIMENTAL
Intervention: Acetazolamide (ACZ) plus diet
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo plus diet
Number of subjects: 126
Study: 36166771

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for 90 days
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 33159533

Group type: EXPERIMENTAL
Intervention: Home-based impact exercise intervention (16 weeks, progressively increasing to 50 multi-directional unilateral hops on each leg daily)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Home-based impact exercise intervention
Number of subjects: 50
Study: 36201325

Group type: EXPERIMENTAL
Intervention: GAL (0.4 g.min‐1)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: GAL+GLU (0.4 g.min‐1 galactose and 0.8 g.min‐1 glucose)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: COMBINE (GAL*+GLU*)
Number of subjects: 14

Group type: COMPARATOR
Intervention: GLU (0.8 g.min‐1)
Number of subjects: 14
Study: 33956804

Group type: EXPERIMENTAL
Intervention: SP16 (0.2 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SP16 (0.0125 mg/kg and 0.05 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SP16
Number of subjects: 0
Study: 32324672

Group type: EXPERIMENTAL
Intervention: Liposomal Bupivacaine (LB)
Number of subjects: 195
Study: 33468340

Group type: EXPERIMENTAL
Intervention: Air cell-based pad
Number of subjects: 27

Group type: COMPARATOR
Intervention: Gel pad
Number of subjects: 27
Study: 35277845

Group type: EXPERIMENTAL
Intervention: Pre-freezing PBM exposure (810 nm, diode laser, and 0.6 J/cm2)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional sperm cryopreservation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Post freezing and thawing PBM exposure
Number of subjects: 24
Study: 33317612

Group type: EXPERIMENTAL
Intervention: Minimally invasive radical trachelectomy (MIRT)
Number of subjects: 414

Group type: COMPARATOR
Intervention: Abdominal radical trachelectomy (ART)
Number of subjects: 414
Study: 35507955

Group type: EXPERIMENTAL
Intervention: Momordica charantia (MC) 2000 mg/day for 12 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 34893092

Group type: EXPERIMENTAL
Intervention: Prefabricated contoured foot orthoses
Number of subjects: 36

Group type: COMPARATOR
Intervention: Flat shoe insoles
Number of subjects: 36
Study: 33920725

Group type: EXPERIMENTAL
Intervention: Selenium yeast (200 µg/day) and coenzyme Q10 (200 mg/day)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 32508211

Group type: EXPERIMENTAL
Intervention: Attribution-retraining
Number of subjects: 565

Group type: COMPARATOR
Intervention: Health education (Control)
Number of subjects: 565
Study: 32377302

Group type: EXPERIMENTAL
Intervention: Plasma selenium concentrations in MetS group (93.88 μg/L)
Number of subjects: 1279

Group type: COMPARATOR
Intervention: Quartile 1 (<82.36 μg/L)
Number of subjects: 1279

Group type: COMPARATOR
Intervention: Quartile 2 (82.37-92.66 μg/L)
Number of subjects: 1279

Group type: COMPARATOR
Intervention: Quartile 3 (92.67-103.52 μg/L)
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Cubic spline analysis of plasma selenium
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Plasma selenium
Number of subjects: 1279

Group type: COMPARATOR
Intervention: GA and GA+AA genotype carriers
Number of subjects: 1279
Study: 36451466

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 12 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 76
Study: 32647353

Group type: EXPERIMENTAL
Intervention: Neoadjuvant SBRT delivered in three fractions of 8 Gy over 5 days completed 2 weeks before surgery
Number of subjects: 16

Group type: COMPARATOR
Intervention: No neoadjuvant SBRT
Number of subjects: 16
Study: 32588788

Group type: EXPERIMENTAL
Intervention: Hemospray therapy
Number of subjects: 73
Study: 34348648

Group type: EXPERIMENTAL
Intervention: LightGBM model
Number of subjects: 1796
Study: 33075037

Group type: EXPERIMENTAL
Intervention: Decision rule-guided antibiotic prescription (n = 402)
Number of subjects: 999

Group type: COMPARATOR
Intervention: Usual care (n = 597)
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Cost-of-illness for children under 5 years with suspected lower RTIs
Number of subjects: 999
Study: 32273250

Group type: EXPERIMENTAL
Intervention: 3D printed model of Henle trunk plus surgical video (3D‐printing group)
Number of subjects: 47

Group type: COMPARATOR
Intervention: 2D image of Henle trunk plus surgical video (2D image group)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 3D printed model of Henle trunk
Number of subjects: 47

Group type: COMPARATOR
Intervention: 2D image group
Number of subjects: 47
Study: 34952302

Group type: EXPERIMENTAL
Intervention: Synchronous classes (n=60)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Asynchronous classes (n=67)
Number of subjects: 127
Study: 32586433

Group type: EXPERIMENTAL
Intervention: Shamiri group intervention (4-week intervention including growth mindset, gratitude, and value affirmation exercises)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Study skills control intervention (4-week control intervention)
Number of subjects: 51
Study: 35500012

Group type: EXPERIMENTAL
Intervention: Emotion regulation instructions (distancing from an emotionally evocative film clip)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Emotion regulation instructions (immersing in the film clip)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Viewing affirming film clip
Number of subjects: 168

Group type: COMPARATOR
Intervention: Viewing minority stress film clip
Number of subjects: 168
Study: 33084081

Group type: EXPERIMENTAL
Intervention: Ketamine (20 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 30
Study: 34398961

Group type: EXPERIMENTAL
Intervention: Exposure to health news stories and social media posts featuring conflict at Times 1 and 2
Number of subjects: 2716

Group type: COMPARATOR
Intervention: Exposure to health news stories and social media posts that did not feature conflict at Times 1 and 2
Number of subjects: 2716
Study: 35502891

Group type: EXPERIMENTAL
Intervention: Healthy Divas intervention (6 peer-led individual sessions and one group workshop)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 278
Study: 32196636

Group type: EXPERIMENTAL
Intervention: Structured physical activity (PA) intervention including two center-based plus three to four home-based exercise sessions per week, aiming for 150 minutes of walking weekly for 2.5 years on average
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Structured physical activity (PA) intervention
Number of subjects: 507
Study: 33501845

Group type: EXPERIMENTAL
Intervention: Adaptive Cogmed Working Memory Training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonadaptive (control) Cogmed Working Memory Training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both Cogmed groups (Adaptive and Nonadaptive)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parent-reported measures
Number of subjects: 0
Study: 33298305

Group type: EXPERIMENTAL
Intervention: e‐SBIRT
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: SBIRT
Number of subjects: 439

Group type: COMPARATOR
Intervention: EUC
Number of subjects: 439
Study: 34375444

Group type: EXPERIMENTAL
Intervention: ACT-based intervention
Number of subjects: 94

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 94
Study: 34694346

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 15 mg once daily
Number of subjects: 7107

Group type: COMPARATOR
Intervention: Aspirin 100 mg once daily
Number of subjects: 7107
Study: 33316278

Group type: EXPERIMENTAL
Intervention: Navigator group
Number of subjects: 932

Group type: EXPERIMENTAL
Intervention: Nonwhite race
Number of subjects: 932
Study: 33183320

Group type: EXPERIMENTAL
Intervention: BUDCA (berberine ursodeoxycholate) at a dose of 2000 mg per day for 28 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 35428650

Group type: EXPERIMENTAL
Intervention: Treg therapy (TR001)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard clinical care (control)
Number of subjects: 60
Study: 34303447

Group type: EXPERIMENTAL
Intervention: Challenging Horizons Program (CHP)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Community Care (CC)
Number of subjects: 186
Study: 33754516

Group type: EXPERIMENTAL
Intervention: 4mg submucosal dexamethasone
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 35867209

Group type: EXPERIMENTAL
Intervention: Risk-score model incorporating factors such as age, sex, immune compromise, presence of microsatellites, and regional nodal involvement.
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Risk-score model with ≤ 4.00 points
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Risk-score model with > 4.00 points
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Pathologic stage I/II patients with > 4.00 points (n = 49)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Pathologic stage III patients with ≤ 4.00 points (n = 62)
Number of subjects: 604
Study: 32778017

Group type: EXPERIMENTAL
Intervention: Cyclosporine, Methotrexate, and Mycophenolate Mofetil
Number of subjects: 134

Group type: COMPARATOR
Intervention: Cyclosporine and Methotrexate
Number of subjects: 134
Study: 33998561

Group type: EXPERIMENTAL
Intervention: Purposeful activity-based electrical stimulation therapy (PA‐EST) for 3 months (phase 1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard stretching and exercise for 3 months (phase 2)
Number of subjects: 8
Study: 33215554

Group type: EXPERIMENTAL
Intervention: Internet-Delivered Cognitive Behavioral Therapy (Living with Deadly Thoughts)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Attention Control Condition
Number of subjects: 418
Study: 33306414

Group type: EXPERIMENTAL
Intervention: RRx-001 (4 mg once weekly until progression)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Etoposide platinum (EP) chemotherapy (etoposide 100 mg/m2 IV on days 1-3, cisplatin 80 mg/m2 IV on day 1 or carboplatin AUC 5-6 IV on day 1)
Number of subjects: 14
Study: 32795267

Group type: EXPERIMENTAL
Intervention: Problem-based learning (n = 79)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Home-sent patient information (controls; n = 78)
Number of subjects: 157
Study: 34999207

Group type: EXPERIMENTAL
Intervention: Vascepa 2 g twice daily
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Fenofibrate 145 mg daily
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Fenofibrate in patients with baseline triglycerides <250 mg/dL
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Fenofibrate in patients with baseline triglycerides ≥250 mg/dL
Number of subjects: 66
Study: 32945207

Group type: EXPERIMENTAL
Intervention: Type B lenses
Number of subjects: 80

Group type: COMPARATOR
Intervention: X50
Number of subjects: 80
Study: 32996444

Group type: EXPERIMENTAL
Intervention: Antibiotic administration
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Change in gut microbial diversity
Number of subjects: 155
Study: 35751891

Group type: EXPERIMENTAL
Intervention: Kundur (Boswellia serrata) 1g vaginal insert daily for 21 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Miconazole (2% w/w) 100mg vaginal suppository daily for 7 days
Number of subjects: 40
Study: 34491649

Group type: EXPERIMENTAL
Intervention: Bo's abdominal acupuncture (combined with methotrexate treatment)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Methotrexate tablets (5 mg once a week)
Number of subjects: 104
Study: 32971304

Group type: EXPERIMENTAL
Intervention: Functional Pavlovian co-conditioning mechanism
Number of subjects: 0
Study: 35564645

Group type: EXPERIMENTAL
Intervention: Elevate Self Growth program
Number of subjects: 19
Study: 34300205

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-remifentanil (DR group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Propofol-remifentanil (PR group)
Number of subjects: 62
Study: 34552035

Group type: EXPERIMENTAL
Intervention: Isometric trunk strength (ITS) testing for trunk flexors, extensors, and lateral flexors
Number of subjects: 567
Study: 33165312

Group type: EXPERIMENTAL
Intervention: Higher levels of attrition
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Exclusion of participants from analyses
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Lack of good control of incomplete outcome data
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Analysis by 'as treated'
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Analysis by 'per protocol'
Number of subjects: 7
Study: 35842108

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with paroxetine or venlafaxine extended release
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Combination of PE and medication
Number of subjects: 450
Study: 33382069

Group type: EXPERIMENTAL
Intervention: SEMA-CD
Number of subjects: 57

Group type: COMPARATOR
Intervention: SES-CD
Number of subjects: 57
Study: 36299678

Group type: EXPERIMENTAL
Intervention: Nonpharmacological integrated care protocols and standard care
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 116
Study: 35918624

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg every 8 hours (control group)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg at breakfast and lunch, placebo at dinner (experimental group)
Number of subjects: 11
Study: 33315111

Group type: EXPERIMENTAL
Intervention: Coronary CTA
Number of subjects: 10003

Group type: EXPERIMENTAL
Intervention: Coronary CTA with FFRCT
Number of subjects: 10003

Group type: COMPARATOR
Intervention: Functional testing
Number of subjects: 10003
Study: 34669586

Group type: EXPERIMENTAL
Intervention: Preprocedural C-reactive protein (CRP) ≥2 mg/L
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Preprocedural HbA1c ≥6% (42 mmol/mol)
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Preprocedural creatinine clearance (CrCl) <60 ml/min
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Non-use of statins
Number of subjects: 1800
Study: 34309111

Group type: EXPERIMENTAL
Intervention: Caregiver-oncologist discordance in patient's life expectancy estimates
Number of subjects: 0
Study: 32854653

Group type: EXPERIMENTAL
Intervention: Conventional ultrasound and contrast-enhanced ultrasound (CEUS) features for diagnosing HAE
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Simplified US scoring system for diagnosing HAE
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional ultrasound findings for HAE lesions
Number of subjects: 120

Group type: COMPARATOR
Intervention: CEUS findings for HAE lesions
Number of subjects: 120
Study: 35643520

Group type: EXPERIMENTAL
Intervention: Ma’s bamboo‐based medicinal moxibustion therapy
Number of subjects: 312

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 312
Study: 32133778

Group type: EXPERIMENTAL
Intervention: Triprolidine 2.5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Triprolidine 5 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Triprolidine 2.5 mg + Pseudoephedrine 60 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Adverse effects
Number of subjects: 24
Study: 32361019

Group type: EXPERIMENTAL
Intervention: EGCG
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Green Tea
Number of subjects: 47

Group type: COMPARATOR
Intervention: Chlorhexidine (CHX)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Distilled Water
Number of subjects: 47
Study: 35869772

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen (HF group)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional mask oxygen (M group)
Number of subjects: 56
Study: 33358241

Group type: EXPERIMENTAL
Intervention: Endopelvic fascia-preserving RALP
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group (standard operation)
Number of subjects: 158
Study: 36472675

Group type: EXPERIMENTAL
Intervention: Family-based treatment involving 10–12 sessions attended by the mother and an identified family member (father) at each session.
Number of subjects: 32
Study: 33023579

Group type: EXPERIMENTAL
Intervention: Pyriproxyfen added to permethrin-treated bed nets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Permethrin-treated bed nets without pyriproxyfen
Number of subjects: 0
Study: 34882193

Group type: EXPERIMENTAL
Intervention: Fixed orthodontic treatment after periodontal stabilization
Number of subjects: 36

Group type: COMPARATOR
Intervention: Periodontal maintenance only (control group)
Number of subjects: 36
Study: 32311845

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) at 5 cmH2O
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combined CPAP with Sustained Inflation (SI; 15 seconds at 25 cmH2O after 5 seconds of CPAP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (CPAP only)
Number of subjects: 18
Study: 36422809

Group type: EXPERIMENTAL
Intervention: DWP16001 (2 mg) + Metformin (1000 mg bid for 7 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin (1000 mg bid for 7 days)
Number of subjects: 0
Study: 33065133

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 1
Study: 32100719

Group type: EXPERIMENTAL
Intervention: Subcutaneous collagen injection (Group A, n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Periradicular collagen injection (Group B, n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Epidural collagen injection (Group C, n = 10)
Number of subjects: 30
Study: 616062701

Group type: EXPERIMENTAL
Intervention: Mitosis Kinase Score (MKS) assessed at surgery
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Mitosis Kinase Score (MKS) before treatment
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Mitosis Kinase Score (MKS) in paired samples after treatment
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Mitosis Kinase Score (MKS) in ER+ patients
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Mitosis Kinase Score (MKS) in ER- patients
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: p21 expression at surgery
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: p21 expression in ER+ patients
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: p21 expression in ER- patients
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Combination of MKS and p21 expression
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Risk groups based on MKS and p21
Number of subjects: 417
Study: 35543888

Group type: EXPERIMENTAL
Intervention: Adaptive preventive intervention (API)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 0
Study: 32644148

Group type: EXPERIMENTAL
Intervention: Epimacular brachytherapy (EMB) plus as-needed ranibizumab
Number of subjects: 363

Group type: COMPARATOR
Intervention: Ranibizumab monotherapy
Number of subjects: 363
Study: 35171317

Group type: EXPERIMENTAL
Intervention: 1 g meropenem, 3-h infusion
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 2 g meropenem, 3-h infusion
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 1 g meropenem, 6-h infusion
Number of subjects: 45
Study: 34641946

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (CBT)
Number of subjects: 95
Study: 32418546

Group type: EXPERIMENTAL
Intervention: (-)-OSU6162 treatment
Number of subjects: 30
Study: 35589459

Group type: EXPERIMENTAL
Intervention: Decision aid outlining the benefits and harms of shoulder surgery and non‐surgical options
Number of subjects: 425

Group type: COMPARATOR
Intervention: General information about shoulder pain from the NHS
Number of subjects: 425
Study: 33302116

Group type: EXPERIMENTAL
Intervention: 500 mg/day elemental calcium
Number of subjects: 791

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 791
Study: 35511770

Group type: EXPERIMENTAL
Intervention: Navigation group (O-arm image guidance system)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Navigation group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Navigation group and Traditional group
Number of subjects: 20
Study: 36042056

Group type: EXPERIMENTAL
Intervention: ZOL + Sr-89
Number of subjects: 30

Group type: COMPARATOR
Intervention: ZOL
Number of subjects: 30
Study: 33035762

Group type: EXPERIMENTAL
Intervention: Chronic cocaine users (CCUs)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cocaine use during the previous month
Number of subjects: 24

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 24
Study: 35817581

Group type: EXPERIMENTAL
Intervention: Individualised feedback on potentially inappropriate prescribing (PIP) of bronchodilator inhalers; feedback included visualised medication histories and action-oriented messages, sent in July 2015, February 2016, and August 2016.
Number of subjects: 233

Group type: COMPARATOR
Intervention: Control group received feedback on an unrelated subject.
Number of subjects: 233

Group type: COMPARATOR
Intervention: Comparison of intervention vs control practices.
Number of subjects: 233
Study: 33397667

Group type: EXPERIMENTAL
Intervention: STRIDE intervention (6 weekly 1-hour sessions via videoconferencing)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Medication monitoring control group (electronic pill bottle and usual oncology care)
Number of subjects: 75
Study: 33355251

Group type: EXPERIMENTAL
Intervention: Various implementation strategies
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Paced learning approaches
Number of subjects: 33
Study: 32636122

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 2030

Group type: EXPERIMENTAL
Intervention: WHR
Number of subjects: 2030
Study: 32443961

Group type: EXPERIMENTAL
Intervention: Home-based monitoring system for self-monitored blood glucose and blood pressure values
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33548222

Group type: EXPERIMENTAL
Intervention: Button
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Handgrip
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control
Number of subjects: 12